Species Differences in the Biotransformation of a New Antiarrhythmic Agent: Disopyramide Phosphate
Overview
Pharmacy
Authors
Affiliations
In vitro Metabolism of Bumetanide.
Grosa G, Viola F, Caputo O, Biglino G Pharm Res. 2013; 1(6):274-6.
PMID: 24277363 DOI: 10.1023/A:1016302203941.
Giacomini K, Swezey S, Blaschke T J Pharmacokinet Biopharm. 1982; 10(1):1-14.
PMID: 7069575 DOI: 10.1007/BF01059180.
Clinical pharmacokinetics of disopyramide.
Karim A, Nissen C, AZARNOFF D J Pharmacokinet Biopharm. 1982; 10(5):465-94.
PMID: 6762414 DOI: 10.1007/BF01059032.
Clinical pharmacokinetics of disopyramide.
Siddoway L, Woosley R Clin Pharmacokinet. 1986; 11(3):214-22.
PMID: 3524956 DOI: 10.2165/00003088-198611030-00003.
Vanhoutte F, Vereecke J, Carmeliet E, Verbeke N Naunyn Schmiedebergs Arch Pharmacol. 1991; 344(6):662-73.
PMID: 1775199 DOI: 10.1007/BF00174750.